947results about How to "Prevent obesity" patented technology

Methods for treating and preventing obesity, inhibiting adipocyte differentiation, inhibiting increased SCD-1 gene transcription, and / or reducing body fat in a subject include administering at least one analog of 1α,25-dihydroxyvitamin D3 or 1α,25-dihydroxyvitamin D2 or a pharmaceutical composition that includes such an analog to a subject in need thereof. The analog may be a 19-nor vitamin D analog such as a compound of formula IA, a compound of formula IB, or a mixture thereof where the variables R1, R2, and R3 have the values described herein.

The oil or fat composition of the invention contains a monoacylglycerol and / or a diacylglycerol in a total amount of 5-100 wt. % and which exhibits an index of stability against oxidation (induction time as measured through a Rancimat test conducted at 100° C.) of 7 or higher, wherein the monoacylglycerol and / or the diacylglycerol contain, as fatty acid constituents, ω3 unsaturated fatty acids in amounts of 15-90 wt. %. Through ingestion thereof in a small amount without drastically changing the person's lifestyle, the highly harmless oil / fat composition of the present invention provides effects for reducing and preventing accumulation of body fat, for reducing and preventing accumulation of visceral fat, and for prevention and treatment of obesity; and exerts an excellent prevention and treatment effect on life-style related diseases through long-term ingestion. Thus, the composition of the present invention is useful for foods, pharmaceuticals and pet food or feed.

The invention concerns a method to treat and / or prevent childhood obesity comprising administering a nutritional composition containing fat, digestible carbohydrates and protein, wherein the protein comprises at least 25 wt. % peptides with a chain length of 25 to 30 amino acids based on dry weight of protein.

A bowl for containing food for an animal, the bowl including: an interior volume for accommodating the food, the interior volume being defined by a base and an upwardly extending circumferential sidewall, wherein at least one protruding portion extends upwardly from the base of the bowl into the interior volume to obstruct the animal from consuming the food too fast.

The invention discloses nutritional health-care fine dried noodles which are developed with suaeda salsa, stigma maydis and Chinese herbal medicines such as the root of kudzu vine, gynostemma pentaphyllum, cortex phellodendri, dandelions, cornus officinalis, radix rehmanniae preparata, herba portulacae, herba houttuyniae, licorice root and stevia rebaudiana as raw materials and have the effects of reducing blood lipid and blood pressure, improving organism immunity, beautifying the face and clearing away toxins, resisting fatigue and the like. The fine dried noodles contain rich functional activated substances such as suaeda salsa and amino acid, polypeptides, water-soluble dietary fibers, ferulic acid, active polysaccharides, saponin and flavone in the Chinese herbal medicines. The fine fried noodles have the advantages that compatibility of suaeda salsa and the Chinese herbal medicines is scientific, functional components in the Chinese herbal medicines are extracted through the technologies including ultrasonic secondary crushing, enzymolysis combined compound microorganism degradation and microwave assisted extraction method, the content of organic selenium in the product is increased, the nutritional healthy functions of the product are remarkably improved, and market prospects are wide.

An object of the present invention is to provide an easy-understandable representation of fat tissue and lean tissue respectively occupying in a body constitution of a subject. Another object thereof is to help the subject determine which one of the fat tissue or the lean tissue is decreasing by weight reduction. A body type determination apparatus according to the present invention calculates an index of body fat mass, FMI (Fat Mass Index: fat mass / body height2), an index of lean mass, LMI (Lean Mass Index: lean mass / body height2), and a body build index, BMI (Body Mass Index: body weight / body height2) from entered body data and a measured bioelectric impedance, and further the apparatus displays a relationship between the BMI and the FMI and / or between the BMI and the LMI as a result of measurement by way of a graph and / or an illustration.

The invention discloses a method for preparing lactobacillus microcapsules, which relates to a method for preparing microcapsules. The method solves the defects that the prior method for preparing thelactobacillus microcapsules cannot obtain dry lactobacillus microcapsule powder easily, the lactobacilli are diffused unevenly, the mortality rate of the lactobacilli is high in the preparation process, a used crosslinking agent has certain toxicity, and the yield of the lactobacillus microcapsules is low. The method for preparing the lactobacillus microcapsules comprises the following steps: firstly, mixing a core material and a wall material; secondly, preparing a primary emulsion; thirdly, preparing a microcapsule oil solution; fourthly, preparing a multiple emulsion; and fifthly, performing condensation, solidification and vacuum freeze drying. The method for preparing the lactobacillus microcapsules can obtain the dry lactobacillus microcapsule powder and avoid the defects of the uneven diffusion of the lactobacilli and the high mortality rate by means of the vacuum freeze drying; the method uses no crosslinking agents and has no toxic action on the lactobacilli; the external water phase is not miscible with the internal water phase; and the yield of the lactobacillus microcapsules prepared by the method reaches 84.6 percent, and the freeze-drying survival rate reaches over 60.107 percent.

The invention discloses weight-losing meal replacement powder which is prepared from the following raw materials: protein power, fruit powder, dietary fibers, plant powder, a sweetening agent, a taste improver and water soluble vitamins. The preparation process comprises the following steps: performing material acceptance, burdening, mixing, performing sterilizing treatment, performing quantitative packing, checking, boxing and warehousing. The weight-losing meal replacement powder prepared according to the invention is low in calorie and high in satiety and is capable of supplementing high-quality proteins, vitamins, mineral substances and dietary fibers, so that balanced diet is realized. Meanwhile, due to the addition of fatty taste improver, good taste can be maintained. Moreover, the body weight can be reduced while enjoying delicious foods, so that an excellent physical state of the human body is maintained.

This invention relates to imidazopyrimidine substituted piperidine derivatives and their use as pharmaceuticals.

The invention discloses a technology for making coated soybean cheese. The technology for making the coated soybean cheese comprises the following three steps of: A) preparing soybean milk; B) making soybean cheese by mixed fermentation; and C) preparing the coated soybean cheese. The soybean milk is obtained by ultrasonic treatment after soybean is thermally pulped. The soybean cheese is obtained by squeezing soybean curd formed under the co-action of inoculated lactic acid bacteria leaven for fermenting and added D-gluconic acid-delta-lactone (GDL). The coated soybean cheese is prepared by using the soybean cheese subjected to limited enzymolysis as a raw material. The coated soybean cheese which is not added with any milk product components has good flavor property, coated property anddeliquescence in mouth.

An object of the present invention is to provide an easy-understandable representation of fat tissue and lean tissue respectively occupying in a body constitution of a subject. Another object thereof is to help the subject determine which one of the fat tissue or the lean tissue is decreasing by weight reduction. A body type determination apparatus according to the present invention calculates an index of body fat mass, FMI (Fat Mass Index: fat mass / body height2), an index of lean mass, LMI (Lean Mass Index: lean mass / body height2), and a body build index, BMI (Body Mass Index: body weight / body height2) from entered body data and a measured bioelectric impedance, and further the apparatus displays a relationship between the BMI and the FMI and / or between the BMI and the LMI as a result of measurement by way of a graph and / or an illustration.

The invention discloses a tartary buckwheat complex tea. The tartary buckwheat complex tea is obtained by using tartary buckwheat as main raw material, blending the tartary buckwheat with a finished product tea, and packaging the tea by using a visible nylon and degradable material packaging bag through ultrasonic sealing. The blending ratio of the complex tea is as follows: in each 100 g complex tea, the content of the tartary buckwheat is 50-70 g and the content of the finished product tea is 30-50 g by weight. The complex tea disclosed by the invention has both nutritional values of the tartary buckwheat and health care function of the tea; and fragrances of the tartary buckwheat and the tea are organically blended so that the taste, fragrance and nutritional value of the complex tea are all largely superior to those of the traditional tartary buckwheat tea, green tea or black tea; and mellow taste and attractive fragrance are obtained so that double requirements on taste and health are both satisfied.

There are provided foods and beverages that will suppress the absorption of dietary lipids, thereby suppressing the rise of triglyceride in blood. High-molecular weight polyphenol fractions recovered from oolong tea are added to foods or beverages as an active ingredient for inhibiting lipase activity. The foods and beverages of the present invention are safe and their inherent flavor has not been impaired; hence, they may be taken in routinely so that the lipase inhibitory action of the high-molecular weight polyphenol fractions will suppress the rise of triglyceride in blood and prevent obesity.

The present invention is related to novel use of piperine, and more specifically, it is related to a pharmaceutical or food composition for preventing and treating obesity comprising piperine or a salt thereof as an active ingredient. The present invention is related to novel use of piperine, and it provides a pharmaceutical or food composition for preventing and treating obesity comprising piperine or a salt thereof as an active ingredient. The composition comprising piperine of the present disclosure is effective on suppression of abdominal fat accumulation and body weight loss. Therefore, the composition can be effectively used to prevent and treat obesity.